Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy

NCT05120076 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-12

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of Dexamethasone on postoperative pain and nausea after periacetabular osteotomy.

Conditions

  • Pain
  • Postoperative Nausea
  • Amount of Postoperative Opioid Use in Milligrams

Interventions

DRUG

Dexamethasone 4 Mg/mL Injectable Solution

s. arm/group description

DRUG

NaCl 0.9%

s. arm/group description

Sponsors & Collaborators

  • Balgrist University Hospital

    lead OTHER

Principal Investigators

  • Patrick Zingg, MD · Study Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-16
Primary Completion
2024-07-31
Completion
2024-08-31
FDA Drug
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120076 on ClinicalTrials.gov